---
document_datetime: 2025-12-02 06:34:12
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/airexar-spiromax.html
document_name: airexar-spiromax.html
version: success
processing_time: 0.1166575
conversion_datetime: 2025-12-24 03:25:06.533626
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Airexar Spiromax

[RSS](/en/individual-human-medicine.xml/66839)

##### Withdrawn

This medicine's authorisation has been withdrawn

salmeterol xinafoate / fluticasone propionate Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Airexar Spiromax](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 15 April 2019, the European Commission withdrew the marketing authorisation for Airexar Spiromax (salmeterol / fluticasone propionate) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Teva B.V., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Airexar Spiromax was granted marketing authorisation in the EU on 18 August 2016 for the treatment of asthma and COPD. Airexar Spiromax was a duplicate application to Aerivio Spiromax, which is marketed in several EU countries.

The European Public Assessment Report (EPAR) for Airexar Spiromax is updated to indicate that the marketing authorisation is no longer valid.

Airexar Spiromax : EPAR - Summary for the public

Reference Number: EMA/513708/2016

English (EN) (238.39 KB - PDF)

**First published:** 05/09/2016

**Last updated:** 05/09/2016

[View](/en/documents/overview/airexar-spiromax-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-783)

български (BG) (293.22 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/bg/documents/overview/airexar-spiromax-epar-summary-public_bg.pdf)

español (ES) (235.92 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/es/documents/overview/airexar-spiromax-epar-summary-public_es.pdf)

čeština (CS) (279.24 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/cs/documents/overview/airexar-spiromax-epar-summary-public_cs.pdf)

dansk (DA) (234.48 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/da/documents/overview/airexar-spiromax-epar-summary-public_da.pdf)

Deutsch (DE) (237.15 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/de/documents/overview/airexar-spiromax-epar-summary-public_de.pdf)

eesti keel (ET) (232.73 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/et/documents/overview/airexar-spiromax-epar-summary-public_et.pdf)

ελληνικά (EL) (300.71 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/el/documents/overview/airexar-spiromax-epar-summary-public_el.pdf)

français (FR) (236.83 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/fr/documents/overview/airexar-spiromax-epar-summary-public_fr.pdf)

hrvatski (HR) (255.83 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/hr/documents/overview/airexar-spiromax-epar-summary-public_hr.pdf)

italiano (IT) (233.72 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/it/documents/overview/airexar-spiromax-epar-summary-public_it.pdf)

latviešu valoda (LV) (277.31 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/lv/documents/overview/airexar-spiromax-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (261.2 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/lt/documents/overview/airexar-spiromax-epar-summary-public_lt.pdf)

magyar (HU) (276.73 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/hu/documents/overview/airexar-spiromax-epar-summary-public_hu.pdf)

Malti (MT) (281.6 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/mt/documents/overview/airexar-spiromax-epar-summary-public_mt.pdf)

Nederlands (NL) (235.1 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/nl/documents/overview/airexar-spiromax-epar-summary-public_nl.pdf)

polski (PL) (279.54 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/pl/documents/overview/airexar-spiromax-epar-summary-public_pl.pdf)

português (PT) (235.51 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/pt/documents/overview/airexar-spiromax-epar-summary-public_pt.pdf)

română (RO) (260.6 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/ro/documents/overview/airexar-spiromax-epar-summary-public_ro.pdf)

slovenčina (SK) (277.97 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/sk/documents/overview/airexar-spiromax-epar-summary-public_sk.pdf)

slovenščina (SL) (270.34 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/sl/documents/overview/airexar-spiromax-epar-summary-public_sl.pdf)

Suomi (FI) (233.81 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/fi/documents/overview/airexar-spiromax-epar-summary-public_fi.pdf)

svenska (SV) (234.34 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/sv/documents/overview/airexar-spiromax-epar-summary-public_sv.pdf)

## Product information

Airexar Spiromax : EPAR - Product Information

English (EN) (902.84 KB - PDF)

**First published:** 05/09/2016

**Last updated:** 12/10/2018

[View](/en/documents/product-information/airexar-spiromax-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-124)

български (BG) (1.72 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/bg/documents/product-information/airexar-spiromax-epar-product-information_bg.pdf)

español (ES) (993.83 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/es/documents/product-information/airexar-spiromax-epar-product-information_es.pdf)

čeština (CS) (1.46 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/cs/documents/product-information/airexar-spiromax-epar-product-information_cs.pdf)

dansk (DA) (905.76 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/da/documents/product-information/airexar-spiromax-epar-product-information_da.pdf)

Deutsch (DE) (1.03 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/de/documents/product-information/airexar-spiromax-epar-product-information_de.pdf)

eesti keel (ET) (1.05 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/et/documents/product-information/airexar-spiromax-epar-product-information_et.pdf)

ελληνικά (EL) (1.64 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/el/documents/product-information/airexar-spiromax-epar-product-information_el.pdf)

français (FR) (1.29 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/fr/documents/product-information/airexar-spiromax-epar-product-information_fr.pdf)

hrvatski (HR) (1.05 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/hr/documents/product-information/airexar-spiromax-epar-product-information_hr.pdf)

íslenska (IS) (1010.31 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/is/documents/product-information/airexar-spiromax-epar-product-information_is.pdf)

italiano (IT) (1.13 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/it/documents/product-information/airexar-spiromax-epar-product-information_it.pdf)

latviešu valoda (LV) (1.35 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/lv/documents/product-information/airexar-spiromax-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.01 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/lt/documents/product-information/airexar-spiromax-epar-product-information_lt.pdf)

magyar (HU) (1.34 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/hu/documents/product-information/airexar-spiromax-epar-product-information_hu.pdf)

Malti (MT) (1.54 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/mt/documents/product-information/airexar-spiromax-epar-product-information_mt.pdf)

Nederlands (NL) (1003.06 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/nl/documents/product-information/airexar-spiromax-epar-product-information_nl.pdf)

norsk (NO) (887.52 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/no/documents/product-information/airexar-spiromax-epar-product-information_no.pdf)

polski (PL) (1.3 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/pl/documents/product-information/airexar-spiromax-epar-product-information_pl.pdf)

português (PT) (891.57 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/pt/documents/product-information/airexar-spiromax-epar-product-information_pt.pdf)

română (RO) (1.14 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/ro/documents/product-information/airexar-spiromax-epar-product-information_ro.pdf)

slovenčina (SK) (1.33 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/sk/documents/product-information/airexar-spiromax-epar-product-information_sk.pdf)

slovenščina (SL) (1.34 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/sl/documents/product-information/airexar-spiromax-epar-product-information_sl.pdf)

Suomi (FI) (813.57 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/fi/documents/product-information/airexar-spiromax-epar-product-information_fi.pdf)

svenska (SV) (1.05 MB - PDF)

**First published:**

05/09/2016

**Last updated:**

12/10/2018

[View](/sv/documents/product-information/airexar-spiromax-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0003 19/02/2018

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Airexar Spiromax : EPAR - All Authorised presentations

English (EN) (172.03 KB - PDF)

**First published:** 05/09/2016

**Last updated:** 05/09/2016

[View](/en/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-427)

български (BG) (179.61 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/bg/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_bg.pdf)

español (ES) (151.24 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/es/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_es.pdf)

čeština (CS) (169.54 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/cs/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (149.93 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/da/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (150.46 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/de/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (150.45 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/et/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (179.12 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/el/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_el.pdf)

français (FR) (151.06 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/fr/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (157.84 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/hr/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (21.24 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/is/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_is.pdf)

italiano (IT) (150.83 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/it/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (173.03 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/lv/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (166.33 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/lt/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (162.37 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/hu/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (173.45 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/mt/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (150.53 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/nl/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (21.32 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/no/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_no.pdf)

polski (PL) (163.77 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/pl/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_pl.pdf)

português (PT) (151.28 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/pt/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_pt.pdf)

română (RO) (158.35 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/ro/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (171.84 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/sk/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (161.8 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/sl/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (150.03 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/fi/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (150.75 KB - PDF)

**First published:**

05/09/2016

**Last updated:**

05/09/2016

[View](/sv/documents/all-authorised-presentations/airexar-spiromax-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Airexar Spiromax Active substance

- salmeterol
- fluticasone propionate

International non-proprietary name (INN) or common name

- salmeterol xinafoate
- fluticasone propionate

Therapeutic area (MeSH)

- Pulmonary Disease, Chronic Obstructive
- Asthma

Anatomical therapeutic chemical (ATC) code R03AK06

### Pharmacotherapeutic group

Drugs for obstructive airway diseases

### Therapeutic indication

Airexar Spiromax is indicated for use in adults aged 18 years and older only.

Asthma

- patients not adequately controlled on a lower strength corticosteroid combination product

or

- patients already controlled on a high dose inhaled corticosteroid and long-acting ? 2 agonist.

Chronic Obstructive Pulmonary Disease (COPD)Airexar Spiromax is indicated for the symptomatic treatment of patients with COPD, with a FEV 1 &lt;60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.

## Authorisation details

EMA product number EMEA/H/C/004267 Marketing authorisation holder

Teva B.V.

Swensweg 5 2031GA Haarlem The Netherlands

Opinion adopted 23/06/2016 Marketing authorisation issued 18/08/2016 Withdrawal of marketing authorisation 15/04/2019 Revision 2

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Airexar Spiromax : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (224.13 KB - PDF)

**First published:** 04/04/2017

**Last updated:** 12/10/2018

[View](/en/documents/procedural-steps-after/airexar-spiromax-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Airexar Spiromax : EPAR - Public assessment report

Adopted

Reference Number: EMA/486131/2016

English (EN) (1.15 MB - PDF)

**First published:** 05/09/2016

**Last updated:** 05/09/2016

[View](/en/documents/assessment-report/airexar-spiromax-epar-public-assessment-report_en.pdf)

CHMP summary of opinion for Airexar Spiromax

Adopted

Reference Number: EMA/CHMP/431246/2016

English (EN) (223.32 KB - PDF)

**First published:** 24/06/2016

**Last updated:** 24/06/2016

[View](/en/documents/smop-initial/chmp-summary-opinion-airexar-spiromax_en.pdf)

#### News on Airexar Spiromax

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 June 2016](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-june-2016) 24/06/2016

- [Clinical data](https://clinicaldata.ema.europa.eu/web/cdp/home?p_p_id=cdpdossierviewportlet_WAR_cdpdossierviewportlet=0=maximized=view=column-3=2=EMEAHC0042670000) (initial marketing authorisation)

**This page was last updated on** 02/07/2019

## Share this page

[Back to top](#main-content)